Basic information Safety Supplier Related

Isoquinoline, 5-iodo- (9CI)

Basic information Safety Supplier Related

Isoquinoline, 5-iodo- (9CI) Basic information

Product Name:
Isoquinoline, 5-iodo- (9CI)
Synonyms:
  • Isoquinoline, 5-iodo- (9CI)
  • Isoquinoline, 5-iodo-
  • DSRM-3716 (Synonyms: 5-Iodoisoquinoline)
  • DSRM3716,SARM1,DSRM-3716,NADase,neurodegenerative,cADPR,Inhibitor,5-Iodoisoquinoline,DSRM 3716,axon,inhibit
  • DSRM-3716, 10 mM in DMSO
CAS:
58142-99-7
MF:
C9H6IN
MW:
255.06
EINECS:
604-604-1
Product Categories:
  • ISOQUINOLINE
Mol File:
58142-99-7.mol
More
Less

Isoquinoline, 5-iodo- (9CI) Chemical Properties

Boiling point:
336.8±15.0 °C(Predicted)
Density 
1.837±0.06 g/cm3(Predicted)
storage temp. 
2-8°C(protect from light)
solubility 
Ethanol:25.51(Max Conc. mg/mL);100.0(Max Conc. mM)
DMSO:25.51(Max Conc. mg/mL);100.0(Max Conc. mM)
form 
solid
pka
4.48±0.13(Predicted)
color 
Yellow to brown
More
Less

Safety Information

HS Code 
2933491090
More
Less

Isoquinoline, 5-iodo- (9CI) Usage And Synthesis

Uses

DSRM-3716 (5-Iodoisoquinoline) is a potent and selective SARM1 NADase inhibitor with an IC50 of 75 nM. DSRM-3716 is selective against other NAD+-processing enzymes, receptors, and transporters. DSRM-3716 provides robust axon protection[1].

Biological Activity

DSRM-3716 is a potent and selective SARM1 NADase inhibitor (NAD+ hydrolysis IC50 = 75 nM using recombinant SARM1 SAM-TIR construct) th at recapitulates the SARM1-/- phenotype and protects axons from degeneration induced by axotomy (EC50 = 2.1/1.9 μM by fragmentation/NfL release using mouse DRG neurons; 81/88% protection by 1/3 μM DSRM-3716 using human iPSC-derived motor neurons) or mitochondrial dysfunction (3-30 μM DSRM-3716 against 25 μM rotenone-induced injury; mouse DRG neurons). Mechanistically, DSRM-3716 undergoes base exchange with the nicotinamide (NAM) moiety of nicotinamide adenine dinucleotide (NAD+) to yield the bona fide inhibitor 1AD.

Synthesis

1125-60-6

58142-99-7

Step A - Preparation of Intermediate 58-1: To a hydrochloric acid/water (40 mL/40 mL) solution of 5-aminoisoquinoline (14 g, 97.2 mmol) was added sodium nitrite (8 g, 116 mmol) in batches at 0 °C. The reaction mixture was stirred at 0 °C for 1 h. Potassium iodide (32 g, 194 mmol) was then added slowly and the mixture was refluxed overnight. Upon completion of the reaction, the mixture was cooled to room temperature, poured into ammonia (40 mL) and extracted with dichloromethane (50 mL x 3). The organic layers were combined, washed with brine (40 mL), dried over anhydrous sodium sulfate and concentrated. The residue was purified by column chromatography (eluent: ethyl acetate/petroleum ether=1:10) to give Intermediate 58-1 (6.5 g). Mass spectrum (ESI): m/z (M+H)+ 256.

storage

Store at -20°C

References

[1] Robert O Hughes, et al. Small Molecule SARM1 Inhibitors Recapitulate the SARM1 -/- Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate. Cell Rep. 2021 Jan 5;34(1):108588. DOI:10.1016/j.celrep.2020.108588

Isoquinoline, 5-iodo- (9CI)Supplier

Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
Santai Labs, Inc.
Tel
519-85601385
Email
marketing@santailabs.com
Shanghai Synthfine Chemical Co.,Ltd
Tel
15921303235
Email
sales@synthfine.com